You are here

Article Text

Article menu
Download PDFPDF
Electronic pages
Letter
The reasons of higher NT-proBNP depend on very different conditions
  1. Mehmet Aydogan1,
  2. Sevket Balta2,
  3. Omer Kurt3,
  4. Hakan Sarlak3,
  5. Seyfettin Gumus1,
  6. Sait Demirkol2
  1. 1Department of Pulmonary Medicine, Gulhane Medical Faculty, Ankara, Turkey
  2. 2Department of Cardiology, Gulhane Medical Faculty, Ankara, Turkey
  3. 3Department of Internal Medicine, Gulhane Medical Faculty, Ankara, Turkey
  1. Correspondence to Dr Mehmet Aydogan, Tevfik Saglam Street, Gulhane Medical Faculty, Department of Pulmonary Medicine, 06018, Etlik, Ankara, Turkey; aydogan542@gmail.com

http://dx.doi.org/10.1136/annrheumdis-2013-203768

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read the article ‘'N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis (IP): results from the Norfolk Arthritis Registry (NOAR)’’ by Mirjafari et al1 with interest. The authors aimed to measure serum NT-pro-BNP levels in a large, well-characterised inception cohort of patients with early IP and examine baseline association of NT-pro-BNP levels with IP disease phenotype, clinical cardiovascular disease (CVD) risk markers and subclinical atherosclerosis surrogates. They concluded that in early IP patients, elevated NT-pro-BNP is related to Health Assessment Questionnaire …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.